Key terms

About VCEL

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VCEL news

Apr 15 7:37am ET Vericel price target raised to $56 from $53 at BTIG Mar 26 8:50am ET Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL) Mar 24 9:40pm ET Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL) Mar 18 4:24pm ET Vericel management to meet with Truist Mar 01 8:14am ET Vericel price target raised to $54 from $51 at Truist Mar 01 7:53am ET Vericel price target raised to $47.40 from $42.40 at Ladenburg Mar 01 7:40am ET Analysts Conflicted on These Healthcare Names: Vericel (VCEL), Tenet Healthcare (THC) and Veeva Systems (VEEV) Mar 01 6:26am ET Buy Rating Affirmed for Vericel on Strong Financials and Growth Prospects Mar 01 6:24am ET Vericel price target raised to $53 from $46 at H.C. Wainwright Feb 29 8:02am ET Vericel sees 2024 revenue $237M-$241M, consensus $240.82M Feb 29 7:59am ET Vericel reports Q4 EPS 26c, consensus 17c Feb 22 5:25am ET BTIG Keeps Their Buy Rating on Vericel (VCEL) Feb 20 7:32am ET Vericel price target raised to $53 from $49 at BTIG Feb 20 6:15am ET BTIG Remains a Buy on Vericel (VCEL) Jan 25 9:49am ET Tesla, Boeing downgraded: Wall Street’s top analyst calls Jan 25 9:49am ET Tesla, Boeing downgraded: Wall Street’s top analyst calls Jan 25 6:06am ET Vericel upgraded to Buy from Hold at Truist Jan 19 7:29am ET Vericel price target raised to $42.40 from $40 at Ladenburg

No recent press releases are available for VCEL

VCEL Financials

1-year income & revenue

Key terms

VCEL Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VCEL Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms